The Effect Of Cadmium (Cd) Treatment On Somatosensory Evoked Potentials (Seps) And Conduction Velocity In Alloxane-Induced Diabetic Rats: Relation To Lipid Peroxidation

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 10, Issue 1, 1999, Pages 41-56

  Agar, Aysel ^a   Edremitlioglu, Mustafa ^a   Kara, Cengiz ^a   Yargi, Piraye ^b   şOguz, Yurtta ^c  

^a Departments of Physiology   (Turkey)

^b Biophysics and Neurology   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

Author keywords

cadmium; conduction velocity; diabetes; rat; SEPs; TBARS

Indexed keywords

ALLOXAN; CADMIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EVOKED SOMATOSENSORY RESPONSE; LIPID PEROXIDATION; MALE; NERVE CONDUCTION; NERVE STIMULATION; NONHUMAN; POSTERIOR TIBIAL NERVE; RAT; SCIATIC NERVE;

ACTION POTENTIALS; ANIMALS; BRAIN; CADMIUM; DIABETES MELLITUS, EXPERIMENTAL; ELECTRIC STIMULATION; EVOKED POTENTIALS, SOMATOSENSORY; KIDNEY; LIPID PEROXIDATION; MALE; NEURAL CONDUCTION; RATS; REACTION TIME; SCIATIC NERVE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0032765623     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.1999.10.1.41     Document Type: Article

References (65)

1. Trick, GL, Burde, RM, Gordon, MO, Kilo, C, Santiago, JV. Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials. Doc Ophthalmol 1988; 70: 19–28.
2. Martinelii, V, Piatti, PM, Filippi, M, Pacchioni, M, Pastore, MR, Canal, N, Comi, G. Effects of hyperglycaemia on visual evoked potentials in insulindependent diabetic patients. ActaDiabetol 1992, 29: 34–37.
3. Low, PA, Schmelzer, JD, Ward, KK, Yao, JK. Experimental chronic hypoxic neuropathy: Relevance to diabetic neuropathy. Am J Physiol 1986; 250: E94-E96.
4. Cameron, NE, Cotter, MA, Low, PA. Nerve blood flow in early experimental diabetes in rats. Relation to conduction deficits. Am J Physiol 1991; 261: El-E8.
5. Cameron, NE, Cotter, MA. Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: Evidence from experimental studies. Diabetic Med 1993; 10: 593–605.
6. Hotta, N, Koh, N, Sakakibara, F, Nakamura, J, Hamada, Y, Wakao, T, Hara, T, Mori, K, Naruse, K, Nakashima, E, Sakamoto, N. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. J Pharmacol Exp Ther 1996; 276: 49–55.
7. Baynes, JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405–412.
8. Sato, Y, Hotta, N, Sakamoto, N, Matsuoka, S, Ohishi, N, Yagi, K. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979; 21: 104–107.
9. Halliwell, B, Gutteridge, JMC, Cross, CE. Free radicals antioxidants and human disease: Where are we now? J Lab Clin Med 1992; 119: 598–620.
10. Asayama, K, Uchida, N, Nakane, T, Hayashibe, H, Dobashi, K, Amemiya, S, Kato, K, Nakazawa, S. Antioxidants in the serum of children with insulindependent diabetes mellitus. Free Radie Biol Med 1993; 15: 597–602.
11. Asayama, K, Nakane, T, Uchida, N, Hayashibe, H, Dobashi, K, Nakazawa, S. Serum antioxidant status in streptozotocin-induced diabetic rat. Horm Metab Res 1994; 26: 313–3151.
12. Wohaieb, SA, Godin, DV. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987; 36: 1014–1018.
13. Goto, Y. Lipid peroxides as a cause of vascular disease. In: Yagi K, ed. Lipid Peroxides in Biology and Medicine. New York: Academic Press, 1982; 295–303.
14. Gulati, S, Gill, KD, Nath, R. Effect of cadmium on lipid composition of the weanling rat brain. Acta Pharmacol Toxicol 1986; 59: 89–93.
15. Shukla, GS, Srivastava, RS, Chandra, SV. Glutathione status and cadmium neurotoxicity studies in discrete brain regions of growing rats. Fund Appl Toxicol 1988; 11: 229–235.
16. Sole, J, Huguet, J, Arola, L, Romeu, A. In vivo effects of nickel and cadmium in rats on lipid peroxidation and ceruloplasmin activity. Bull Environ Contam Toxicol 1990; 44: 686–691.
17. Manca, D, Ricard, AC, Trottier, B, Chevalier, G. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 1991; 67: 303–323.
18. Manca, D, Ricard, AC, Trottier, B, Chevalier, G. In vitro and in vivo responses of tissues to cadmium-induced lipid peroxidation. Bull Environ Contam Toxicol 1991; 46: 929–936.
19. Hudecova, A, Ginter, E. The influence of ascorbic acid on lipid peroxidation in guinea pigs intoxicated with cadmium. Food Chem Toxicol 1992; 30: 1011–1013.
20. Ali, MM, Shukla, GS, Srivastava, RS, Mathur, N, Chandra, SV. Effects of vitamin E on cadmium-induced locomotor dysfunctions in rats. Vet Hum Toxicol 1993; 35: 109–111.
21. Sidhu, M, Sharma, M, Bhatia, M, Awasthi, YC, Nath, R. Effect of chronic cadmium exposure on glutathione S-transferase and glutathione peroxidase activities in Rhesus monkey: the role of selenium. Toxicology 1993; 83: 203–213.
22. Nechay, B, Saunders, JP. Inhibitor characteristic of cadmium, lead and mercury in human sodium and potassium dependent adenosine triphosphatase preparations. J Environ Pathol Toxicol 1978; 2: 283–290.
23. Gulati, S, Gill, KD, Nath, R. Effect of cadmium on lipid metabolism of brain: in vivo incorporation of labelled acetate into lipids. Pharmacol Toxicol 1987; 60: 117–119.
24. Roeleveld, N, Zielhuis, GA, Gabreel, F. Occupational exposure and defects of the central nervous system in offspring: Review. Br J Indust Med 1990; 47: 580–588.
25. Tacey, E, White, K, Baggs, RE, Miller, RK. Central nervous system lesions in the Wistar rat fetus following direa fetal injections of cadmium. Teratology 1990; 42: 7–13.
26. Newland, MG, Wendy, W, Raymond, NG, Baggs, RE, Gentry, GD, Weiss, B, Miller, RK. Operant behaviour in transition reflects neonatal exposure to cadmium. Teratology 1986; 34: 231–241.
27. Hussain, T, Shukla, GS, Chandra, SV. Effects of cadmium on superoxide dismutase and lipid peroxidation in liver and kidney of growing rats: in vivo and in vitro studies. Pharmacol Toxicol 1987; 60: 355–358.
28. Rajanna, B, Hobson, M, Reese, J, Sample, E, Chapatwala, KD. Chronic hepatic and renal toxicity by cadmium in rats. Drug Chem Toxicol 1984; 7: 229–241.
29. Howaniec, M, Mekail, A, Chroszcz, G. The role of cernitins in cadmium effect on the absorption processes in rat small intestine. Acta Physiol Pol 1988; 39: 189–194.
30. Marlowe, M, Errera, J, Jacobs, J. Increased lead and cadmium burdens among mentally retarded children with borderline intelhgence. Am J Men Defic 1983; 87: 477–483.
31. Eisen, A. The somatosensory evoked potential. Can J Neurol Sci 1982; 9: 65–77.
32. Tsuji, S, Lueders, H, Lesser, RP, Dinner, DS, Klem, G. Subcortical and cortical somatosensory potentials evoked by posterior tibial nerve stimulation. Normative values. Electroenceph Clin Neurophysiol 1984; 59: 214–228.
33. Sen, CN, Mailer, AR. Comparison of somatosensory evoked potentials recorded from the scalp and dorsal column nuclei to upper and lower limb stimulation in the rat. Electroenceph Clin Neurophysiol 1991; 80: 378–383.
34. Apaydm, C, Oguz, Y, Agar, A, Yargiçoglu, P, Demir, N, Aksu, G. Visual evoked potentials and optic nerve histopathology in normal and diabetic rats and effect of ginkgo biloba extract. Acta Ophthalmol 1993; 71: 1–7.
35. Agar, A, Yargiçoglu, P, Apaydm, KC, Oguz, Y. The effect of ginkgo biloba extract on EEG spectra in experimental diabetes: No relation to lipid peroxidation. Int J Neurosci 1994; 76: 259–266.
36. Gill, TS, Pant, JC. Cadmium toxicity. Inducement of changes in blood and tissue metabolites in fish. Toxicol Lett 1983; 18: 195–200.
37. Durrant, JD, Gerich, JE, Mitrakou, HA, Jenssen, T, Hyre, RJ. Changes in BAEP under hypoglycemia are temperature-related. Electroenceph Clin Neurophysiol 1991; 80: 547–550.
38. Panjwani, GD, Mustafa, MKY, Muhailan, A, Aneja, IS, Owunwanne, A. Effect of hyperthermia on somatosensory evoked potentials in the anaesthetized rat. Electroenceph Clin Neurophysiol 1991; 80: 384–391.
39. Stocks, JO, Dormandy, TL. Autooxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 1971; 20: 95–111.
40. Stocks, JO, Offerman, EL, Modell, CB, Dormandy, TL. The susceptibihty to autooxidation of human red cell lipids in health and disease. Br J Haematol 1972; 23: 713–724.
41. Lowry, OH, Rosenbrough, NJ, Farr, AL, Randell, RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.
42. Baselt, RC. Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology. Davis, CA: Biomedical Publications, 1980; 60–63.
43. Hart, DT, Borowitz, JL. Adrenal catecholamine release by divalent mercury and cadmium. Arch Int Pharmocodyn Ther 1974; 209: 94–99.
44. Shanbaky, IO. Borowitz, JL, Kessler, WV. Mechanisms of cadmium and brain-induced adrenal catecholamine release. Toxicol Appl Pharmacol 1978; 44: 99–105.
45. Merali, Z, Singhal, RL. Diabetogenic effect of chronic oral cadmium administration to neonatal rats. Br J Pharmacol 1980; 69: 151–158.
46. Bell, RR, Early, JL, Nonavinakere, VK, Mallory, Z. Effect of cadmium on blood glucose level in the rat. Toxicol Lett 1990; 54: 199–205.
47. Sugawara, N. Effect of dietary cadmium on serum and liver lipids in mice in relation to interaction of essential metals, zinc, copper and iron. Toxicol Sci 1984; 9: 29–36.
48. Suzuki, KT, Tamagawa, H, Takahashi, K, Shimajo, N. Pregnancy-induced mobilization of copper and zinc bound to renal metallothionein in cadmium loaded rats. Toxicology 1990; 60: 199–222.
49. Dowman, R, Rosenfeld, P. Effects of naloxane and repeated stimulus presentation on cortical somatosensory evoked potential (SEP) amplitude in the rat. Exp Neurol 1985; 89: 9–23.
50. Sakatani, K, lizuka, H, Young, W. Somatosensory evoked potentials in rat cerebral cortex before and after middle cerebral artery occlusion. Stroke 1990; 21: 124–132.
51. Yargiçoglu, P, Agar, A, Oǧuz, Y, Öner, G. The effect of hypercholesterolemia on SEPs recorded from rats. Int J Neurosci 1991; 61: 93–99.
52. Todorava, A, Bayagieva, M, Yosifov, T. Effect of endothelin on somatosensory evoked potentials in rats. Neuropsychobiology 1992; 26: 108–112.
53. Gupta, PR, Dorfman, LJ. Spinal somatosensory conduction in diabetes. Neurology 1981; 31: 841–845.
54. Thatcher, RW, McAlaster, R, Lester, ML. Evoked potentials related to hair cadmium and lead in children. Ann NY Acad Sci 1984; 425: 384–390.
55. Pozzessere, G, Rizzo, PA, Valle, E, Mollica, MA, Meccia, A, Morano, S, Di Mario, U, Andreani, D, Morocutti, C. Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care 1988; 11: 473–480.
56. Pozzessere, G, Valle, E, Crignis, SD, Cordischi, VM, Fattapposta, F, Rizzo, PA, Pietravalle, P, Cristina, G, Morano, S, Di Mario, U. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric tests. Diabetes 1991; 40: 952–958.
57. Yargiçoglu, P, Agar, A, Oguz, Y, Uysal-izgüt, VN, Şentürk, K, Öner, G. The effect of developmental exposure to cadmium (Cd) on visual evoked potentials (VEPs) and lipid peroxidation. Neurotoxicol Teratol 1997; 19: 213–217.
58. Cracco, RQ. Spinal evoked response: peripheral nerve stimulation in man. Electroenceph Clin Neurophysiol 1973; 35: 379–386.
59. Desmedt, JE, Cheron, G. Central somatosensory conduction in man: neural generators and interpeak latencies of the far field components recorded from neck and right or left scalp and ear lobes. Electroenceph Clin Neurophysiol 1980; 50: 382–403.
60. Greenberg, RP, Ducker, TB. Evoked potentials in the clinical neurosciences. J Neurosurg 1982; 56: 1–18.
61. Shaw, NA, Synek, VM. Somatosensory evoked potentials following stimulation of the tibial, peroneal and sural nerves using four different montages. Clin Electroenceph 1985; 16: 149–156.
62. Sima, AAF, Brismar, T. Reversible diabetic nerve dysfunction: Structural correlates to electrophysiological abnormalities. Ann Neurol 1985; 18: 21–29.
63. Cracco, J, Castells, S, Mark, E. Spinal somatosensory evoked potentials in juvenile diabetes. Ann Neurol 1984; 15: 55–58.
64. Cameron, NE, Cotter, MA, Robertson, S. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q J Exp Physiol 1989; 74: 917–926.
65. Stevens, EJ, Tomlinson, DR. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br J Pharmacol 1995; 115; 373–379.